Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 13:17:45 UTC
Update Date2021-09-26 23:07:55 UTC
HMDB IDHMDB0254131
Secondary Accession NumbersNone
Metabolite Identification
Common NameLixivaptan
DescriptionLixivaptan, also known as VPA-985, belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. Based on a literature review a significant number of articles have been published on Lixivaptan. This compound has been identified in human blood as reported by (PMID: 31557052 ). Lixivaptan is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Lixivaptan is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
5-Fluoro-2-methyl-N-(4-(5H-pyrrolo(2,1-c)-(1,4)benzodiazepin-10-(11H)-ylcarbonyl)-3-chlorophenyl)benzamideHMDB
N-4-(3-Chloro-4-(5H-pyrrolo(2,1-C)(1,4)benzodiazepin-10(11H)-ylcarbonyl)phenyl)-5-fluoro-2-methylbenzamideHMDB
VPA 985HMDB
VPA-985HMDB
WAY vpa-985HMDB
WAY-vpa-985HMDB
WAY-vpa-985CRTX 080HMDB
VPA-985lixivaptanHMDB
Chemical FormulaC27H21ClFN3O2
Average Molecular Weight473.93
Monoisotopic Molecular Weight473.1306328
IUPAC NameN-(3-chloro-4-{3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),4,6,11,13-pentaene-9-carbonyl}phenyl)-5-fluoro-2-methylbenzamide
Traditional NameN-(3-chloro-4-{3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),4,6,11,13-pentaene-9-carbonyl}phenyl)-5-fluoro-2-methylbenzamide
CAS Registry NumberNot Available
SMILES
CC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(=O)N2CC3=CC=CN3CC3=C2C=CC=C3)C(Cl)=C1
InChI Identifier
InChI=1S/C27H21ClFN3O2/c1-17-8-9-19(29)13-23(17)26(33)30-20-10-11-22(24(28)14-20)27(34)32-16-21-6-4-12-31(21)15-18-5-2-3-7-25(18)32/h2-14H,15-16H2,1H3,(H,30,33)
InChI KeyPPHTXRNHTVLQED-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassAnilides
Direct ParentBenzanilides
Alternative Parents
Substituents
  • Benzanilide
  • 1,4-benzodiazepine
  • Benzodiazepine
  • 2-halobenzoic acid or derivatives
  • 3-halobenzoic acid or derivatives
  • Halobenzoic acid or derivatives
  • Benzamide
  • O-toluamide
  • Benzoic acid or derivatives
  • Toluamide
  • Benzoyl
  • Halobenzene
  • Toluene
  • Fluorobenzene
  • Chlorobenzene
  • Aryl halide
  • Aryl fluoride
  • Aryl chloride
  • Vinylogous halide
  • Tertiary carboxylic acid amide
  • Pyrrole
  • Heteroaromatic compound
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Carboxylic acid derivative
  • Organoheterocyclic compound
  • Azacycle
  • Organohalogen compound
  • Organonitrogen compound
  • Organooxygen compound
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Organochloride
  • Organofluoride
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.99ALOGPS
logP5.98ChemAxon
logS-6ALOGPS
pKa (Strongest Acidic)12.37ChemAxon
pKa (Strongest Basic)-3.1ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area54.34 ŲChemAxon
Rotatable Bond Count3ChemAxon
Refractivity133 m³·mol⁻¹ChemAxon
Polarizability49.25 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+214.36830932474
DeepCCS[M-H]-211.97330932474
DeepCCS[M-2H]-244.85630932474
DeepCCS[M+Na]+220.28130932474
AllCCS[M+H]+210.532859911
AllCCS[M+H-H2O]+208.432859911
AllCCS[M+NH4]+212.332859911
AllCCS[M+Na]+212.832859911
AllCCS[M-H]-192.032859911
AllCCS[M+Na-2H]-191.032859911
AllCCS[M+HCOO]-190.132859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Predicted by Siyang on May 30, 202218.1467 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20220.95 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid3047.0 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid405.3 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid235.8 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid210.1 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid162.1 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid787.9 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid799.8 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)90.0 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid1693.2 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid579.9 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1853.6 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid548.7 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid461.2 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate287.3 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA242.1 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water10.9 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
LixivaptanCC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(=O)N2CC3=CC=CN3CC3=C2C=CC=C3)C(Cl)=C15411.1Standard polar33892256
LixivaptanCC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(=O)N2CC3=CC=CN3CC3=C2C=CC=C3)C(Cl)=C13968.8Standard non polar33892256
LixivaptanCC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(=O)N2CC3=CC=CN3CC3=C2C=CC=C3)C(Cl)=C14091.7Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Lixivaptan,1TMS,isomer #1CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C3842.8Semi standard non polar33892256
Lixivaptan,1TMS,isomer #1CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C3605.5Standard non polar33892256
Lixivaptan,1TMS,isomer #1CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C4740.2Standard polar33892256
Lixivaptan,1TBDMS,isomer #1CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C(C)(C)C4059.1Semi standard non polar33892256
Lixivaptan,1TBDMS,isomer #1CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C(C)(C)C3809.7Standard non polar33892256
Lixivaptan,1TBDMS,isomer #1CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C(C)(C)C4761.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Lixivaptan GC-MS (Non-derivatized) - 70eV, Positivesplash10-002u-9500000000-0bda8b4d08dc950c05692021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lixivaptan GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 10V, Positive-QTOFsplash10-00di-0110900000-55d50135d5b9755068102017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 20V, Positive-QTOFsplash10-000l-0930400000-e3a6a773b6bfa9411cdb2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 40V, Positive-QTOFsplash10-0f79-4930000000-c39675e8fa3fde0d7b712017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 10V, Negative-QTOFsplash10-00di-0000900000-ad1882cf9c75944323382017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 20V, Negative-QTOFsplash10-00di-0402900000-c0299a543c627c5bf9b62017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 40V, Negative-QTOFsplash10-053r-0901000000-3a4fa230b6ad4b25c97d2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 10V, Positive-QTOFsplash10-00di-0000900000-8d3d3c414912f96d5d1e2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 20V, Positive-QTOFsplash10-00dr-0400900000-2c694bde24a438ac5abe2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 40V, Positive-QTOFsplash10-0pir-3900200000-77364acf67a34b244dcd2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 10V, Negative-QTOFsplash10-00di-0000900000-c8865dcac70cb7ee611d2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 20V, Negative-QTOFsplash10-00di-0102900000-f3555a98de2acff1704c2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lixivaptan 40V, Negative-QTOFsplash10-001i-3900000000-19d65f8dd1284a8c794d2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB06666
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID151067
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkLixivaptan
METLIN IDNot Available
PubChem Compound172997
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]